echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Fujian will cut drug costs 4 billion after the Spring Festival results!

    Fujian will cut drug costs 4 billion after the Spring Festival results!

    • Last Update: 2021-02-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Reporters from the Fujian Provincial Health planning committee was informed that, as the first province to complete the provincial tender after the release of the State Office No. 7, Fujian Province is currently in the region procurement complex of drug belt procurement, after the Spring Festival will formally implement a new round of centralized drug procurement results.
    , according to Chen Xiaochun, deputy director of Fujian Provincial Health and Planning Commission and director of the Office of fujian Province's leading group for centralized drug procurement, Fujian Province has now completed the evaluation of various types of procurement catalogs, hanging up the network work. According to preliminary statistics, the average decline of some drug bidding varieties purchased by the current round of public tender was 18.01 percent, the average decline of bargaining varieties was 8.28 percent, and the average decrease of specific price-limiting negotiated drugs was 22.59 percent. It is estimated that the provincial level can save about 4 billion yuan in drug procurement funds.
    perfecting the centralized procurement of medicines in public hospitals is an important content and key link in deepening the reform of the medical and health system, which is of great significance for speeding up the reform of public hospitals, regulating the order of drug circulation and establishing and perfecting the drug supply guarantee system based on the basic drug system. In February 2015, the General Office of the State Council issued the Guidance on Improving the Centralized Procurement of Medicines in Public Hospitals, i.e., State Office No. 7, which proposes to distinguish between different situations of medicines, and to implement different forms of classified procurement such as tender procurement, negotiated procurement, direct online procurement, fixed-point production and special drug procurement.
    " in order to fully implement a new round of centralized procurement of drugs, our province to strengthen the top-level design, the establishment of seven new mechanisms. Chen Xiaochun said that since the launch of a new round of drug procurement in March 2014, the Fujian Provincial Health and Planning Commission has put the policy into practice by exploring new paths and establishing new mechanisms.
    1. Establish a new mechanism for catalog selection
    adhere to the principle of "picking for use, on demand", from the bottom up by the province's medical institutions at all levels according to the needs of clinical drug use, through layer selection, on-demand selection, list publicity and other methods to report Purchase list, provincial re-organization evaluation experts to conduct reasonable audit, the formation of the province's centralized drug procurement catalog list, varieties from the original 2654 to 1791 species, the product rules from the original 11995 to 4917.
    2. Establish a new mechanism for classified procurement
    according to the spirit of document No. 7 of the State Office, according to the plan, step by step through open bidding, price negotiations, centralized networking, fixed-point production and independent sunshine and other means to carry out classified procurement. Strict implementation of the "double envelope" evaluation, the economic and technical score of ≥90 points, listed as the first level, the other classified as the second level, according to the score from high to low to determine the entry into the commercial tender evaluation of pharmaceutical production enterprises, and then according to the commercial bid quotation from low to high to determine the finalist products, by the region procurement complex for volume procurement. The commonly used low-cost drugs to implement differentiated quotation network, reasonable control of the increase, so that low-cost drugs not only meet the clinical supply, but also reasonable prices. For the key monitoring and use of drugs, according to the sales volume of the implementation of a ladder price reduction, the average monthly sales of more than 5 million yuan, from the next month above the limit, according to sales volume of more than 2% (less than 2%, calculated at 2%) purchase price decreased by 0.5% to pay for the drug.
    Three, establish a new mechanism for medical insurance payment
    The Fujian Provincial Joint Conference on Medical Insurance, in accordance with the relevant policy provisions of the State and the actual price situation arising from the centralized procurement of medicines, studies and determines the standards for payment of medical insurance drugs, clarifies the average price of actual drug purchases in the province for the next year or more as the standard for payment of medical insurance drugs, and adjusts the list of reimbursements for medical insurance and new agricultural and B drugs in Fujian Province in due course in accordance with the provisions of the relevant national policies.
    4. Establish a new mechanism for centralized settlement
    the unified choice to determine the centralized settlement of drug procurement to open an account bank, open a settlement account, ensure timely payment of drug payments, reduce the financing costs of enterprises and drug production and circulation costs. Correct and prevent hospitals from delaying payment in disguise, such as acceptance bills of exchange. Medical insurance agencies at all levels are required to settle the medical insurance expenses in a timely manner on a monthly basis and to advance the medical expenses of the previous year's average amount of one month to the designated medical institutions as a work capital.
    5. Establish a new mechanism of incentive and restraint
    the province will be divided into a number of procurement areas, medical institutions according to the procurement area to form a procurement complex, in accordance with the "single source" principle, in the provincial drug centralized procurement on the basis of the finalists, to carry out volume-price-linked drug belt procurement. The difference between the price paid by the medical insurance and the amount purchased with the amount shall be handed over to the financial department at the same level, and the government shall set up a special incentive fund to improve the remuneration and treatment of medical personnel, which shall not be included in the total performance salary of the unit. The difference resulting from the implementation of the step-down price reduction is also handed over to the same level of finance in each procurement area, which is incorporated into the special government incentive fund.
    6th, the establishment of a new mechanism for supervision and management
    formulated and promulgated the Measures for the Administration of Drug Central Procurement Performance Bonds in Medical Institutions (Trial) to strengthen the supervision of drug performance. Unified public selection to determine the province's public medical institutions of basic drug distribution enterprises, strictly limit the number of drug distribution enterprises in each procurement area, improve distribution concentration. Strict implementation of the integrity record and market clearance system, the establishment of pharmaceutical purchase and sale of the field of commercial bribery bad record. Drug production enterprises suspected of commercial bribery shall be disqualified from participating in the current round of procurement, and the social reputation points of the relevant enterprises shall be deducted from the evaluation of economic and technical standards, effectively punishing illegal acts in the field of pharmaceutical purchase and sale.
    7, the establishment of a new procurement platform mechanism
    strengthen the provincial drug centralized procurement platform standardized construction, to achieve connectivity with the national platform, improve the level of intelligence. All public medical institutions in the province must conduct drug transactions on the procurement platform, fully implement information disclosure, and achieve "open and fair, transparent and clean." Strengthen the procurement platform complaints function, timely handling of complaints, strengthen social supervision. (Seber Blue)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.